Monthly Archives: March 2012

March 25, 2012: Uncertainty at its Finest

Week In Review

Barry Ritholtz is “miserably long”

Trouble ahead for Jon Corzine

BATS failed IPO-day

High Frequency Trading

Allan Trend’s Weekly Update

Pretzel Logic's Technical Analysis

Pharmboy's Biotech Corner

Phil's Thoughts on the Week Ahead

March 18, 2012: Culture of Greed

ZERO HEDGE ON THE LOW-VOLUME RALLY

GREG SMITH’S GOODBYE TO GOLDMAN SACHS

LEE ADLER’S WALL STREET EXAMINER

ALLAN TRENDS’ WEEKEND UPDATE

PHARMBOY’S BIOTECHS PHIL & THE WEEK AHEAD

ECONOMIC CALENDAR & CHART LEVELS

March 11, 2011: Market Snapshots

A VISIT WITH DOUG SHORT

3-year anniversary of the bottom

LEE ADLER’S WALL STREET EXAMINER

Peak Deman

SABRIENT

Longs and Shorts

PHIL & THE WEEK AHEAD

PHARMBOY’S BIOTECHS

ECONOMIC CALENDAR & CHART LEVELS

March 4, 2012: Power vs. Truth

SPECIAL EDITION!

Interpretation

Power vs. Truth

LEE ADLER’S WALL STREET EXAMINER

PHARMBOY'S BIOTECH CORNER

SABRIENT'S TOP VALUE STOCKS

PHIL'S OPTIONS TRADES IDEAS